These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9789985)

  • 1. [The role of Lactobacillus acidophilus in the prevention and adjuvant therapy of certain infectious diseases].
    Halmy C; Halmy L
    Orv Hetil; 1998 Sep; 139(39):2313-8. PubMed ID: 9789985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multivalent minigene vaccines against infectious disease.
    An LL; Whitton JL
    Curr Opin Mol Ther; 1999 Feb; 1(1):16-21. PubMed ID: 11249678
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimicrobial and immunomodulatory activities of Lactobacillus acidophilus Ke-10].
    Zalashko MV; Anisimova HI; Bortkevich LG
    Prikl Biokhim Mikrobiol; 1997; 33(3):305-9. PubMed ID: 9297184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of infectious diseases in children.
    Isaacs D
    Compr Ther; 1991 Sep; 17(9):22-6. PubMed ID: 1769194
    [No Abstract]   [Full Text] [Related]  

  • 5. Passive antibody therapy for infectious diseases.
    Casadevall A; Dadachova E; Pirofski LA
    Nat Rev Microbiol; 2004 Sep; 2(9):695-703. PubMed ID: 15372080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clone conception--a contribution to solution of problems in the prevention of infectious diseases].
    Rische H; Tschäpe H; Witte W
    Z Gesamte Hyg; 1984 Jan; 30(1):24-6. PubMed ID: 6711043
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adhesion of lactic acid bacteria to epithelium of different cavities of the human organism].
    Kovalenko NK; Podgorskiĭ VS; Kasumova SA
    Mikrobiol Z; 2004; 66(4):62-8. PubMed ID: 15515903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonal immunoglobulins and hyperimmune globulins in prevention and management of infectious diseases.
    Hsu JL; Safdar N
    Infect Dis Clin North Am; 2011 Dec; 25(4):773-88. PubMed ID: 22054755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling infectious disease - time to think outside the box?
    Wiles S; Hanage WP; Frankel G; Robertson B
    Nat Rev Microbiol; 2006 Apr; 4(4):307-12. PubMed ID: 16518420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population mobility and infectious diseases: the diminishing impact of classical infectious diseases and new approaches for the 21st century.
    Gushulak BD; MacPherson DW
    Clin Infect Dis; 2000 Sep; 31(3):776-80. PubMed ID: 11017829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The use of agents to stimulate and correct the immune system in the prevention of infectious diseases among the troops].
    Degtiarev AA; Furgal SM
    Voen Med Zh; 1990 Jul; (7):56-8. PubMed ID: 2238500
    [No Abstract]   [Full Text] [Related]  

  • 12. Probiotic agents and infectious diseases: a modern perspective on a traditional therapy.
    Alvarez-Olmos MI; Oberhelman RA
    Clin Infect Dis; 2001 Jun; 32(11):1567-76. PubMed ID: 11340528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention of transmissible diseases].
    Seebach J; Bart PA; Spertini F
    Rev Med Suisse; 2010 Apr; 6(245):795-6. PubMed ID: 20469660
    [No Abstract]   [Full Text] [Related]  

  • 14. Why did it take the Infectious Diseases Society of America so long to address the problem of antibiotic resistance?
    Kunin CM
    Clin Infect Dis; 2008 Jun; 46(11):1791-2; author reply 1792-3; discussion 1793-4. PubMed ID: 18462117
    [No Abstract]   [Full Text] [Related]  

  • 15. Type I interferons as vaccine adjuvants against infectious diseases and cancer.
    Bracci L; La Sorsa V; Belardelli F; Proietti E
    Expert Rev Vaccines; 2008 Apr; 7(3):373-81. PubMed ID: 18393607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probiotics, prebiotics, and synbiotics.
    de Vrese M; Schrezenmeir J
    Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Epidemiological aspects of the resistance of infectious agents].
    Perepelkin VS; Spirande VV
    Voen Med Zh; 1978 Jul; (7):46-50. PubMed ID: 354194
    [No Abstract]   [Full Text] [Related]  

  • 19. [The theoretical and practical aspects of the nonspecific prevention of infectious diseases among the troops].
    Semenenko TA; Perepelkin VS; Prozorovskiĭ SV
    Voen Med Zh; 1996 Aug; 317(8):40-3, 80. PubMed ID: 9036646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on Bacillus subtilis and Lactobacillus acidophilus, as potential probiotics, on the immune response and resistance of Tilapia nilotica (Oreochromis niloticus) to challenge infections.
    Aly SM; Abdel-Galil Ahmed Y; Abdel-Aziz Ghareeb A; Mohamed MF
    Fish Shellfish Immunol; 2008 Jul; 25(1-2):128-36. PubMed ID: 18450477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.